These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


180 related items for PubMed ID: 20117090

  • 1. Real-time monitoring of RNA helicase activity using fluorescence resonance energy transfer in vitro.
    Tani H, Fujita O, Furuta A, Matsuda Y, Miyata R, Akimitsu N, Tanaka J, Tsuneda S, Sekiguchi Y, Noda N.
    Biochem Biophys Res Commun; 2010 Feb 26; 393(1):131-6. PubMed ID: 20117090
    [Abstract] [Full Text] [Related]

  • 2. High-throughput screening assay of hepatitis C virus helicase inhibitors using fluorescence-quenching phenomenon.
    Tani H, Akimitsu N, Fujita O, Matsuda Y, Miyata R, Tsuneda S, Igarashi M, Sekiguchi Y, Noda N.
    Biochem Biophys Res Commun; 2009 Feb 20; 379(4):1054-9. PubMed ID: 19150342
    [Abstract] [Full Text] [Related]

  • 3. A fluorescence-based screening assay for identification of hepatitis C virus NS3 helicase inhibitors and characterization of their inhibitory mechanism.
    Furuta A, Salam KA, Tani H, Tsuneda S, Sekiguchi Y, Akimitsu N, Noda N.
    Methods Mol Biol; 2015 Feb 20; 1259():211-28. PubMed ID: 25579589
    [Abstract] [Full Text] [Related]

  • 4. An ELISA for RNA helicase activity: application as an assay of the NS3 helicase of hepatitis C virus.
    Hsu CC, Hwang LH, Huang YW, Chi WK, Chu YD, Chen DS.
    Biochem Biophys Res Commun; 1998 Dec 30; 253(3):594-9. PubMed ID: 9918773
    [Abstract] [Full Text] [Related]

  • 5. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
    Liu D, Wang YS, Gesell JJ, Wyss DF.
    J Mol Biol; 2001 Nov 30; 314(3):543-61. PubMed ID: 11846566
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A.
    Kuang WF, Lin YC, Jean F, Huang YW, Tai CL, Chen DS, Chen PJ, Hwang LH.
    Biochem Biophys Res Commun; 2004 Apr 23; 317(1):211-7. PubMed ID: 15047170
    [Abstract] [Full Text] [Related]

  • 7. Fluorometric assay of hepatitis C virus NS3 helicase activity.
    Krawczyk M, Stankiewicz-Drogoń A, Haenni AL, Boguszewska-Chachulska A.
    Methods Mol Biol; 2010 Apr 23; 587():211-21. PubMed ID: 20225152
    [Abstract] [Full Text] [Related]

  • 8. Direct fluorometric measurement of hepatitis C virus helicase activity.
    Boguszewska-Chachulska AM, Krawczyk M, Stankiewicz A, Gozdek A, Haenni AL, Strokovskaya L.
    FEBS Lett; 2004 Jun 04; 567(2-3):253-8. PubMed ID: 15178332
    [Abstract] [Full Text] [Related]

  • 9. Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
    Kandil S, Biondaro S, Vlachakis D, Cummins AC, Coluccia A, Berry C, Leyssen P, Neyts J, Brancale A.
    Bioorg Med Chem Lett; 2009 Jun 01; 19(11):2935-7. PubMed ID: 19414257
    [Abstract] [Full Text] [Related]

  • 10. Nucleoside triphosphatase and RNA helicase activities associated with GB virus B nonstructural protein 3.
    Zhong W, Ingravallo P, Wright-Minogue J, Skelton A, Uss AS, Chase R, Yao N, Lau JY, Hong Z.
    Virology; 1999 Sep 01; 261(2):216-26. PubMed ID: 10497107
    [Abstract] [Full Text] [Related]

  • 11. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
    Umehara T, Fukuda K, Nishikawa F, Sekiya S, Kohara M, Hasegawa T, Nishikawa S.
    Nucleic Acids Symp Ser (Oxf); 2004 Sep 01; (48):195-6. PubMed ID: 17150545
    [Abstract] [Full Text] [Related]

  • 12. Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins.
    Massariol MJ, Zhao S, Marquis M, Thibeault D, White PW.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):692-7. PubMed ID: 19944069
    [Abstract] [Full Text] [Related]

  • 13. In vitro selection of RNA aptamers against the HCV NS3 helicase domain.
    Nishikawa F, Funaji K, Fukuda K, Nishikawa S.
    Oligonucleotides; 2004 Jan 01; 14(2):114-29. PubMed ID: 15294075
    [Abstract] [Full Text] [Related]

  • 14. Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663.
    Maga G, Gemma S, Fattorusso C, Locatelli GA, Butini S, Persico M, Kukreja G, Romano MP, Chiasserini L, Savini L, Novellino E, Nacci V, Spadari S, Campiani G.
    Biochemistry; 2005 Jul 19; 44(28):9637-44. PubMed ID: 16008349
    [Abstract] [Full Text] [Related]

  • 15. An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activities.
    Fukuda K, Umehara T, Sekiya S, Kunio K, Hasegawa T, Nishikawa S.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):670-5. PubMed ID: 15541341
    [Abstract] [Full Text] [Related]

  • 16. Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3.
    Umehara T, Fukuda K, Nishikawa F, Kohara M, Hasegawa T, Nishikawa S.
    J Biochem; 2005 Mar 17; 137(3):339-47. PubMed ID: 15809335
    [Abstract] [Full Text] [Related]

  • 17. A Brownian motor mechanism of translocation and strand separation by hepatitis C virus helicase.
    Levin MK, Gurjar M, Patel SS.
    Nat Struct Mol Biol; 2005 May 17; 12(5):429-35. PubMed ID: 15806107
    [Abstract] [Full Text] [Related]

  • 18. Probing the relationship between RNA-stimulated ATPase and helicase activities of HCV NS3 using 2'-O-methyl RNA substrates.
    Hesson T, Mannarino A, Cable M.
    Biochemistry; 2000 Mar 14; 39(10):2619-25. PubMed ID: 10704211
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C virus NS3 NTPase/helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step.
    Locatelli GA, Gosselin G, Spadari S, Maga G.
    J Mol Biol; 2001 Nov 02; 313(4):683-94. PubMed ID: 11697897
    [Abstract] [Full Text] [Related]

  • 20. Optimization of the multiple enzymatic activities of the hepatitis C virus NS3 protein.
    Misialek S, Rajagopalan R, Stevens SK, Beigelman L, Seiwert SD, Kossen K.
    Anal Biochem; 2009 Nov 01; 394(1):138-40. PubMed ID: 19591800
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.